Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Rivaroxaban
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
GREEN
Rivaroxaban 10mg, 15mg & 20mg Xarelto
®
( Film Coated Tablets)
Cardiovascular system, Oral anticoagulants, 02.08.02
Amber SPA
Rivaroxaban 2.5mg Xarelto
®
( Film Coated Tablets)
Cardiovascular system, Oral anticoagulants, 02.08.02
GREEN
Dabigatran 75mg & 110mg Pradaxa
®
(Capsules)
Cardiovascular system, Oral anticoagulants, 02.08.02
Links found
MHRA DSU Oct 2018: Rivaroxaban (Xarelto▼) after transcatheter aortic valve replacement: increase in all-cause mortality, thromboembolic and bleeding events in a clinical trial
NICE TA256: Rivaroxaban for AF
NICE TA261: Rivaroxaban for treatment of DVT
NICE TA287: Rivaroxaban for treating PE and preventing recurrent venous thromboembolism
NICE TA335: Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
NICE TA607 Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease